Severo Ochoa Programme 2018-2022 Health NEWS

← Back
Our Partner: https://royalreelspokies.live/ - Royal Reels Australia.

Wednesday, 20 September 2023

INBRAIN Neuroelectronics announces FDA Breakthrough Device Designation for its graphene-based intelligent network modulation platform

A first-of-a-kind device, the INBRAIN Intelligent Network Modulation System is designed to offer a new treatment option for patients with Parkinson’s disease. It harnesses the properties of graphene and the power of machine learning software to provide highly targeted and adaptive neuroelectronic therapy. INBRAIN Neuroelectronics originated as a spin-off company of ICN2 and ICREA, with the participation of the IMB-CNM-CSIC.

Friday, 08 September 2023

DIY nanoelectrodes: an innovative, affordable, and cleanroom-free fabrication technique

A recent publication in 'Small’ introduces a method for manufacturing nanoelectrodes for sensing applications using readily available, low-cost materials and laboratory equipment. Performance tests have demonstrated these electrodes’ high sensitivity. This new fabrication technique, developed by researchers from the ICN2 Nanobielectronics and Biosensors Group, holds the potential to significantly influence the fields of electrochemistry and point-of-care sensing.

Thursday, 29 June 2023

ICN2 Researchers Shine at the 13th Edition of the Graphene Conference Series in Manchester

The 13th edition of the Graphene Conference series, the most prominent European event centered on graphene and 2D materials, is in its final stages in Manchester, UK. The ICN2 has played again a significant role at this year's conference, with numerous members of the institute giving high-profile presentations, including ICN2's Director, Prof. Pablo Ordejón, and ICREA Prof. Stephan Roche acting as members of the Organising Committee.

Monday, 06 March 2023

Nanocapsules with remote control to locally amplify the effect of chemotherapy

A research published in ACS Nano and featured on the cover of the issue proposes externally controlled iron magnetoplasmonic nanocapsules for cancer treatment. Satisfactory results have already been obtained in the preclinical phase in mice. This study was carried out by reseachers from the Barcelona Institute of Microelectronics (IMB-CNM-CSIC), the Catalan Institute of Nanoscience and Nanotechnology (ICN2) and the Hebrew University of Jerusalem (HU).

Wednesday, 01 March 2023

ICN2 showcases four cutting-edge tech spinoffs at 4YFN event

ICN2 showcases four of its most promising spin-off companies at the 4YFN (4 Years From Now) event held in Barcelona during MWC23. InBrain Neuroelectronics, Napptilus Battery Labs, Paperdrop Diagnostics, and Cooling Photonics presented their cutting-edge technologies and business models to potential investors and collaborators.

Friday, 24 February 2023

Two steps in one: Novel laser-based technique simplifies the production of nanostructured films for sensing applications

A study published in ACS sensor and led by members of the ICN2 Nanobioelectronics and Biosensors Group introduces a one-step, versatile technique to produce nanocomposite films (made of reduced graphene oxide embedding metal nanoparticles) to be used as sensing substrates for different applications. The simplicity of this approach can allow scaling sensor production and reducing costs.

Thursday, 26 January 2023

The future of nanomaterials for central nervous system diseases treatment

Experts in various branches of nanomedicine discuss recent developments and provide their vision about the future of the field in a Roadmap article published in the 'Journal of Physics, Materials'. Researchers from the ICN2 Nanostructured Functional Materials Group and the Universitat Autónoma de Barcelona contributed a section dedicated to the use of nanoparticles as carriers for drug delivery in Parkinson’s disease treatments.

Thursday, 01 December 2022

A sensitive photonic nanodevice provides rapid and quantitative diagnostic of COVID-19

A team of researchers led by members of the ICN2 NanoBiosensors and Bioanalytical Applications Group presents on the pages of ‘Sensors & Diagnostics’ an innovative photonic biosensor that can detect the presence of the SARS-COV-2 virus at very low concentrations in a sample. It can also provide a quantitative measure of the viral load in less than 20 minutes, which is crucial to prevent the spread of the infection and to intervene quickly with the appropriate treatment.

Wednesday, 16 November 2022

Three new ICN2 projects receive AGAUR 2021 Grants

Thanks to this funding, researchers at the ICN2 will develop photo-sensitive materials for smart windows, membranes for skin regeneration and a device for rapid detection and discrimination of respiratory viruses.